- Split View
-
Views
-
CiteCitation
Klaus Kisters, Ernst-Rudolf Krefting, Markus Kosel, Karl Heinz Rahn, Martin Hausberg; Intracellular Mg++ concentrations in smooth and striated muscle cells in spontaneously hypertensive rats, American Journal of Hypertension, Volume 13, Issue 4, 1 April 2000, Pages 427–430, https://doi.org/10.1016/S0895-7061(99)00196-X
Download citation file:
© 2018 Oxford University Press
Close -
Share
Abstract
Decreased intracellular Mg++ concentrations seem to be involved in the pathogenesis of primary hypertension. Of special interest is the smooth muscle cell with its electrolyte metabolism in primary hypertension, but also heart muscle cells and their Mg++ concentrations are of growing interest. Therefore, in aortic smooth muscle cells and striated heart muscle cells (left ventricle) from 20 spontaneously hypertensive rats (SHR) of the Münster strain and 20 normotensive Wistar-Kyoto rats (WKY), the intracellular Mg++ content was measured. The electron probe x-ray microanalysis technique was used to determine intracellular Mg++ concentrations under nearly in vivo conditions in aortic cryosections 3 μm thick and striated heart muscle cells 4 μm thick (Camscan CS 24 apparatus). Vascular smooth muscle Mg++ content was 36.4 ± 3.1 mmol/kg dry weight in SHR versus 48.6 ± 3.7 mmol/kg dry weight in WKY (P < .001). In striated heart muscle cell Mg++ concentrations, there was no significant difference in SHR and WKY (79.9 ± 5.6 versus 80.3 ± 5.9 mmol/ kg dry weight). In conclusion, the present study revealed that genetic hypertension in the spontaneously hypertensive rat is accompanied by significantly decreased intracellular Mg++ concentrations in vascular smooth muscle cells. In striated heart muscle cells, Mg++ content was not significantly different in SHR and WKY. Mg++ handling is different in vascular smooth muscle and striated heart muscle cells in WKY and SHR (P < .01).
Changes in Mg++ metabolism have been implicated in the pathogenesis of hypertension.1–5 Whereas plasma Mg++ concentrations have often been investigated, comparatively few data on intracellular Mg++ concentrations are available.6, 7 Furthermore, the role of intracellular Mg++ content in essential hypertension is also controversial.8–11 Decreased intracellular free Mg++ concentrations in erythrocytes of essential hypertensive patients have been described by some workers, whereas others were unable to confirm these findings concerning total erythrocytic Mg++ concentrations.12–15 These different results in intracellular Mg++ content in essential hypertension may be due to various analytical techniques. Most of the results showing a decreased cellular magnesium ion content in primary hypertension were obtained from blood cells, but only sparse data exist concerning intracellular total magnesium ion concentrations in intact vascular smooth muscle cells or intact striated heart muscle cells in hypertension.6, 16–19 Therefore, it was of interest to develop a method to determine total Mg++ content in intact vascular smooth muscle and intact striated heart muscle cells of spontaneously hypertensive and normotensive rats.
Methods
We used the aortae and left ventricle from 20 SHR and 20 WKY (systolic blood pressure 116.3 ± 6.3 mm Hg, means ± SD) aged 9 months. The SHR had reached a systolic blood pressure of 194.4 ± 10.6 mm Hg at this age. The dry heart (g) to body weight (kg) ratio of the SHR was greater than that for the WKY rats (1.7 ± 0.2 versus 1.1 ± 0.2, P < .01), indicating significant hypertrophy of the SHR hearts.
For determination of intracellular magnesium, smooth muscle cells from abdominal rat aorta and striated heart muscle cells of the left ventricle were investigated.
The aortae and the left ventricle were freed of surrounding connective tissue and immediately frozen in liquid propane cooled with liquid nitrogen at approximately −190°C. Cryosections 3 μm thick for aortae and 4 μm thick for heart muscle cells were made and then lyophilized. Magnesium measurements were performed in each sample by electronprobe microanalysis technique as described earlier.18–22
Briefly, for the electronprobe microanalysis, an electron microscope with an x-ray detector system was used (Camscan CS 24 apparatus, Cambridge, UK). When the electrons of the incoming beam strike an atom in the specimen they can knock an electron out of the kernel. If this hole is in an inner shell it is filled with an electron of a higher shell, and an x-ray photon with a discrete energy corresponding to the difference between the two atomic shells is emitted simultaneously. The energy of these X-rays is characteristic for each element. For quantitation, the continuum method developed by Hall was used.23
Intracellular sites of measurements were identified by the morphology obtained by electron microscopy, and by simultaneous measurements of sulphur and phosphorus, the concentrations of which were markedly elevated in the intracellular compared with the extracellular space.
In each aorta and left ventricle the mean values of at least five intracellular measurements at different sites were calculated. All sites were within smooth or striated muscle cells. The magnification was 5 × 10,000 so that the intracellular organelles could be identified. For the magnesium measurements only sites within the cytoplasm were chosen.
The Mg++ content was then expressed in mmol/kg dry weight of the tissue. Data are given as means ± SD. P values < .05 were considered to be significant. Statistical analysis was performed by analysis of variance (ANOVA).
Results
Vascular smooth muscle Mg++ content was 36.4±3.1 mmol/kg dry weight in SHR versus 48.6 ± 3.7 mmol/kg dry weight in WKY (Figure 1, P < .001). In total striated heart muscle cell Mg++ concentrations, there was no significant difference in SHR and WKY (79.9 ± 5.6 versus 80.3 ± 5.9 mmol/kg dry weight) (Figure 2). All values are given as means ± SD.
Intracellular magnesium ion content in aortic smooth muscle cells from 20 normotensive rats (WKY) and 20 SHR (means ± SD, P < .001).
Cellular magnesium concentrations in striated heart muscle cells from 20 WKY and 20 SHR (means ± SD).
There was no correlation between smooth muscle cell magnesium content or striated heart muscle cell magnesium concentrations and blood pressure values in the normotensive or spontaneously hypertensive rats. There was a significant increase in heart muscle to body weight ratio in SHR versus WKY rats (P < .01). No correlation between intracellular Mg++ concentrations, blood pressure values, or total heart muscle weight was found. Intracellular Mg++ handling was different in vascular smooth muscle cells and striated heart muscle cells in WKY and SHR (P < .01).
Discussion
To assess intracellular Mg++ stores appropiately still remains difficult. Red blood cells are not a generally accepted indicator of cellular Mg++ stores. In human studies, only blood cells can routinely be used to measure intracellular Mg++ concentrations. Mg++ measurements in lymphocytes and platelets are complicated by the fact that the volume of these cells is difficult to assess. On the other hand, measurements of cytosolic free Mg++ by the fluorescent dye mag fura II circumvent this difficulty, but can be done only in fresh material, thus obviating the possibility of measuring a greater number of stored samples.
A role for cellular Mg++ concentration in vascular tone has been postulated in hypertension.1–5, 10 In essential hypertensives, Resnick et al found decreased intracellular free Mg++ concentrations in red blood cells as estimated by nuclear magnetic resonance spectroscopy.12 Analogous findings have been reported in the spontaneously hypertensive rat.6, 10, 24, 25
Whereas, from investigations in blood cells, a magnesium deficiency in primary hypertension seems likely, comparatively few data exist on intracellular electrolyte concentrations in vascular smooth muscle cells or in striated heart muscle cells.6, 7, 16–19
An intracellular Mg++ deficiency and possibly a defect in intracellular Mg++ transport could play a pathogenetic role in the development of primary hypertension.6
A Mg++-induced vasodilation may be apparent, owing to 1) an altered response to vasopressor hormones, and 2) an interaction with intracellular Ca++ handling.2
The extracellular Mg++ concentration can influence Ca++ metabolism of vascular smooth muscle by changing the Ca++ influx through the plasma membrane. In single myocytes from frog ventricle, the site of interaction between Mg++ and Ca++ was identified as the Ca++ inward current that is dependent on phosphorylation by cyclic adenosine monophosphatase.24
In addition, changes in extracellular Mg++ concentration induced inverse changes in the Ca++ content of vascular smooth muscle and in exchangeable Ca++.25, 26 A decrease in the intracellular free Mg++ concentration results in diminished membrane Na+, K+ adenosine triphosphatase, and Ca++ ATPase activities and, as a corollary, increased Na+-Ca++ exchange, increased intracellular Na+ and Ca++concentrations,27–34 and disturbed Mg++–Na+ exchanger.18, 19
The results obtained in our study show significantly lower total intracellular Mg++ concentrations under nearly in vivo conditions in vascular smooth muscle cells of SHR as compared to WKY (P < .001). The findings are similar to those in red blood cells of essential hypertensives or in spontaneously hypertensive rats.18, 19
As the present results show, a cellular magnesium deficiency in vascular smooth muscle cells seems likely in the development and pathogenesis of primary hypertension, although the present results cannot evaluate the relative roles of the possible mechanisms.
As described earlier, free magnesium ion content in hypertensive striated heart muscle cells is decreased, although total heart muscle magnesium content as shown in the study presented here was not found to be significantly different.6 For these reasons magnesium handling seems to be different in smooth muscle and striated heart muscle cells, eg, due to different transport mechanisms or transmembrane defects (P < .01). The presented data support the magnesium deficiency theory in vascular smooth muscle cells in the development of primary hypertension.
